RIPE-KG · Version 1.1.0 · Resource
ripekg:publication-details/RIPEAE6C99CEB4A528D11
https://w3id.org/ripe/ripe-kg/publication-details/RIPEAE6C99CEB4A528D11
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEAE6C99CEB4A528D11 |
prov:used |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
prism:eIssn |
1421-9697 |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
prism:endingPage |
48 |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
prism:issn |
0250-6807 |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
prism:publicationDate |
2025-08-28 |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
prism:publicationName |
Annals of Nutrition and Metabolism |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
prism:startingPage |
42 |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
dcterms:publisher |
ripekg:publisher/RIPEP8E8750DABD833A34S. Karger AG |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
dcterms:title |
Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
http://purl.org/spar/fabio/BibliographicMetadata |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
rdfs:Resource |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
owl:Thing |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
ripe:PublicationDetailsPublication details |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
tido:Evidence |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAE6C99CEB4A528D11 |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAE6C99CEB4A528D11 |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripe:concerns |
ripekg:work/10.1159%2F000438465Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE6C99CEB4A528D11-human-1-1 |
ripekg:publication-details/RIPEAE6C99CEB4A528D11Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE6C99CEB4A528D11-inspectai-1-1 |